These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 32135526)
1. A theoretical cell-killing model to evaluate oxygen enhancement ratios at DNA damage and cell survival endpoints in radiation therapy. Matsuya Y; Sato T; Nakamura R; Naijo S; Date H Phys Med Biol; 2020 Apr; 65(9):095006. PubMed ID: 32135526 [TBL] [Abstract][Full Text] [Related]
2. Theoretical effectiveness of cell survival in fractionated radiotherapy with hypoxia-targeted dose escalation. Chvetsov AV; Rajendran JG; Zeng J; Patel SA; Bowen SR; Kim EY Med Phys; 2017 May; 44(5):1975-1982. PubMed ID: 28236652 [TBL] [Abstract][Full Text] [Related]
3. Modelling oxygen effects on the in- and out-of-field radiosensitivity of cells exposed to intensity-modulated radiation fields. Matsuya Y; McMahon SJ; Butterworth KT; Yachi Y; Saga R; Sato T; Prise KM Phys Med Biol; 2023 Apr; 68(9):. PubMed ID: 36958050 [No Abstract] [Full Text] [Related]
4. Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters. Carlson DJ; Stewart RD; Semenenko VA Med Phys; 2006 Sep; 33(9):3105-15. PubMed ID: 17022202 [TBL] [Abstract][Full Text] [Related]
5. Overcoming hypoxia-induced tumor radioresistance in non-small cell lung cancer by targeting DNA-dependent protein kinase in combination with carbon ion irradiation. Klein C; Dokic I; Mairani A; Mein S; Brons S; Häring P; Haberer T; Jäkel O; Zimmermann A; Zenke F; Blaukat A; Debus J; Abdollahi A Radiat Oncol; 2017 Dec; 12(1):208. PubMed ID: 29287602 [TBL] [Abstract][Full Text] [Related]
7. Oxygen-enhanced MRI Is Feasible, Repeatable, and Detects Radiotherapy-induced Change in Hypoxia in Xenograft Models and in Patients with Non-small Cell Lung Cancer. Salem A; Little RA; Latif A; Featherstone AK; Babur M; Peset I; Cheung S; Watson Y; Tessyman V; Mistry H; Ashton G; Behan C; Matthews JC; Asselin MC; Bristow RG; Jackson A; Parker GJM; Faivre-Finn C; Williams KJ; O'Connor JPB Clin Cancer Res; 2019 Jul; 25(13):3818-3829. PubMed ID: 31053599 [TBL] [Abstract][Full Text] [Related]
8. New insights into factors influencing the clinically relevant oxygen enhancement ratio. Daşu A; Denekamp J Radiother Oncol; 1998 Mar; 46(3):269-77. PubMed ID: 9572620 [TBL] [Abstract][Full Text] [Related]
9. Impact of SBRT fractionation in hypoxia dose painting - Accounting for heterogeneous and dynamic tumor oxygenation. Kjellsson Lindblom E; Ureba A; Dasu A; Wersäll P; Even AJG; van Elmpt W; Lambin P; Toma-Dasu I Med Phys; 2019 May; 46(5):2512-2521. PubMed ID: 30924937 [TBL] [Abstract][Full Text] [Related]
10. Oxygen enhancement ratios of cancer cells after exposure to intensity modulated x-ray fields: DNA damage and cell survival. Matsuya Y; McMahon SJ; Butterworth KT; Naijo S; Nara I; Yachi Y; Saga R; Ishikawa M; Sato T; Date H; Prise KM Phys Med Biol; 2021 Apr; 66(7):. PubMed ID: 33735839 [TBL] [Abstract][Full Text] [Related]
11. Adaptation of stochastic microdosimetric kinetic model to hypoxia for hypo-fractionated multi-ion therapy treatment planning. Inaniwa T; Kanematsu N; Shinoto M; Koto M; Yamada S Phys Med Biol; 2021 Oct; 66(20):. PubMed ID: 34560678 [TBL] [Abstract][Full Text] [Related]
12. A modified hypoxia-based TCP model to investigate the clinical outcome of stereotactic hypofractionated regimes for early stage non-small-cell lung cancer (NSCLC). Strigari L; Benassi M; Sarnelli A; Polico R; D'Andrea M Med Phys; 2012 Jul; 39(7):4502-14. PubMed ID: 22830782 [TBL] [Abstract][Full Text] [Related]
13. A radiobiological model of reoxygenation and fractionation effects. Guerrero M; Carlson DJ Med Phys; 2017 May; 44(5):2002-2010. PubMed ID: 28273349 [TBL] [Abstract][Full Text] [Related]
14. Markov chain Monte Carlo analysis for the selection of a cell-killing model under high-dose-rate irradiation. Matsuya Y; Kimura T; Date H Med Phys; 2017 Oct; 44(10):5522-5532. PubMed ID: 28786486 [TBL] [Abstract][Full Text] [Related]
15. A simple mathematical model of cyclic hypoxia and its impact on hypofractionated radiotherapy. Taylor E Med Phys; 2023 Mar; 50(3):1893-1904. PubMed ID: 36594511 [TBL] [Abstract][Full Text] [Related]
16. Radio-sensitization effect of an mTOR inhibitor, temsirolimus, on lung adenocarcinoma A549 cells under normoxic and hypoxic conditions. Ushijima H; Suzuki Y; Oike T; Komachi M; Yoshimoto Y; Ando K; Okonogi N; Sato H; Noda SE; Saito J; Nakano T J Radiat Res; 2015 Jul; 56(4):663-8. PubMed ID: 25887043 [TBL] [Abstract][Full Text] [Related]
17. Generalized Multi-Hit Model of Radiation-Induced Cell Survival with a Closed-Form Solution: An Alternative Method for Determining Isoeffect Doses in Practical Radiotherapy. Zhao L; Chen X; Tian J; Shang Y; Mi D; Sun Y Radiat Res; 2020 Apr; 193(4):359-371. PubMed ID: 32031917 [TBL] [Abstract][Full Text] [Related]
18. Hypofractionation in non-small cell lung cancer (NSCLC): suggestions from modelling both acute and chronic hypoxia. Ruggieri R Phys Med Biol; 2004 Oct; 49(20):4811-23. PubMed ID: 15566177 [TBL] [Abstract][Full Text] [Related]
19. Effects of radiation quality and oxygen on clustered DNA lesions and cell death. Stewart RD; Yu VK; Georgakilas AG; Koumenis C; Park JH; Carlson DJ Radiat Res; 2011 Nov; 176(5):587-602. PubMed ID: 21823972 [TBL] [Abstract][Full Text] [Related]
20. Tumour control in ion beam radiotherapy with different ions in the presence of hypoxia: an oxygen enhancement ratio model based on the microdosimetric kinetic model. Strigari L; Torriani F; Manganaro L; Inaniwa T; Dalmasso F; Cirio R; Attili A Phys Med Biol; 2018 Mar; 63(6):065012. PubMed ID: 28862152 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]